[go: up one dir, main page]

ES2062551T3 - Analogos de ferritina. - Google Patents

Analogos de ferritina.

Info

Publication number
ES2062551T3
ES2062551T3 ES90913110T ES90913110T ES2062551T3 ES 2062551 T3 ES2062551 T3 ES 2062551T3 ES 90913110 T ES90913110 T ES 90913110T ES 90913110 T ES90913110 T ES 90913110T ES 2062551 T3 ES2062551 T3 ES 2062551T3
Authority
ES
Spain
Prior art keywords
ferritine
analogs
inorganic composition
protein
ferrihidrita
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913110T
Other languages
English (en)
Inventor
Bruce Francis Monzyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2062551T3 publication Critical patent/ES2062551T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
    • C04B35/10—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on aluminium oxide
    • C04B35/111—Fine ceramics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00—Photosensitive materials
    • G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/015—Apparatus or processes for the preparation of emulsions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Ceramic Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Structural Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Bipolar Transistors (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ANALOGOS DE FERRITINA QUE CONTIENEN UNA ENVOLTURA DE PROTEINA DE APOFERRITINA Y UN NUCLEO DESPROVISTO SUSTANCIALMENTE DE FERRIHIDRITA, EJ. DE COMPOSICION INORGANICA COMO POR EJEMPLO HIDROXIDO DE ALUMINIO O DE COMPOSICION INORGANICA COMO POR EJEMPLO ACETAMINOFENO. LA ENVOLTURA DE LA PROTEINA SE PUEDE SEPARAR DEL ANALOGO DE FERRITINA PARA PRODUCIR ESFERULAS QUE TENGAN UN DIAMETRO NOMINAL SUSTANCIALMENTE MONOMODAL DE ENTRE 40 Y 100 ANGSTROMS APROXIMADAMENTE.
ES90913110T 1989-08-18 1990-08-03 Analogos de ferritina. Expired - Lifetime ES2062551T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39593489A 1989-08-18 1989-08-18

Publications (1)

Publication Number Publication Date
ES2062551T3 true ES2062551T3 (es) 1994-12-16

Family

ID=23565152

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913110T Expired - Lifetime ES2062551T3 (es) 1989-08-18 1990-08-03 Analogos de ferritina.

Country Status (11)

Country Link
US (2) US5304382A (es)
EP (1) EP0487615B1 (es)
JP (1) JPH04507255A (es)
KR (1) KR950002917B1 (es)
AT (1) ATE99656T1 (es)
AU (1) AU641936B2 (es)
CA (1) CA2064069A1 (es)
DE (1) DE69005827T2 (es)
DK (1) DK0487615T3 (es)
ES (1) ES2062551T3 (es)
WO (1) WO1991002704A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
US6986942B1 (en) 1996-11-16 2006-01-17 Nanomagnetics Limited Microwave absorbing structure
US6713173B2 (en) * 1996-11-16 2004-03-30 Nanomagnetics Limited Magnetizable device
GB2319253A (en) 1996-11-16 1998-05-20 Eric Leigh Mayes Composition, for use in a device, comprising a magnetic layer of domain-separated magnetic particles
US20060003163A1 (en) * 1996-11-16 2006-01-05 Nanomagnetics Limited Magnetic fluid
US6815063B1 (en) 1996-11-16 2004-11-09 Nanomagnetics, Ltd. Magnetic fluid
US6180389B1 (en) 1997-01-03 2001-01-30 The Research And Development Institute, Inc. Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules
WO1998032902A1 (en) * 1997-01-22 1998-07-30 Ester Guy R Method of manufacturing crystalline particles on a support or a substrate
US6514453B2 (en) * 1997-10-21 2003-02-04 Nanoproducts Corporation Thermal sensors prepared from nanostructureed powders
WO2001068834A1 (en) * 2000-03-16 2001-09-20 Matsushita Electric Industrial Co., Ltd. Nucleotide detector, process for producing the same and process for forming fine particle membrane
DE10042023C2 (de) * 2000-08-08 2003-04-10 Biognostic Ag Kapseln, die feste Teilchen signalerzeugender Substanzen einkapseln, und deren Verwendung bei Bioassays zum Nachweis von Zielmolekülen in einer Probe
EP1262489A1 (en) 2001-05-14 2002-12-04 Matsushita Electric Industrial Co., Ltd. Complex comprising recombinant ferritin and a precious metal and DNA encoding said ferritin
JP3588602B2 (ja) * 2001-10-01 2004-11-17 松下電器産業株式会社 コバルト−タンパク質複合体の作製方法
US7282710B1 (en) 2002-01-02 2007-10-16 International Business Machines Corporation Scanning probe microscopy tips composed of nanoparticles and methods to form same
AU2003272187A1 (en) * 2002-02-01 2004-01-06 Montana State University Novel nanoparticles and use thereof
US6897650B2 (en) * 2002-02-11 2005-05-24 International Business Machines Corporation Magnetic-field sensor device
WO2003094849A2 (en) * 2002-05-10 2003-11-20 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
US20040115132A1 (en) * 2002-05-17 2004-06-17 Young Mark J. Protein cages for the delivery of medical imaging and therapeutic agents
WO2003099708A1 (en) * 2002-05-28 2003-12-04 Matsushita Electric Industrial Co., Ltd. Process for producing nanoparticle and nanoparticle produced by the process
JP3703479B2 (ja) * 2002-09-20 2005-10-05 松下電器産業株式会社 ナノ粒子の製造方法及び該製造方法によって製造されたナノ粒子
GB2393729A (en) * 2002-10-04 2004-04-07 Nanomagnetics Ltd Semiconductor nanoparticles
EP1608977B1 (en) * 2003-04-02 2007-08-15 Turun Yliopisto Nanoparticle for bioaffinity assays
FI20030615A0 (fi) * 2003-04-24 2003-04-24 Marko Virta Nanopartikkeli bioaffiniteettimäärityksiin
US6972095B1 (en) 2003-05-07 2005-12-06 Electric Power Research Institute Magnetic molecules: a process utilizing functionalized magnetic ferritins for the selective removal of contaminants from solution by magnetic filtration
EP1571198A1 (en) * 2004-03-02 2005-09-07 Dalli-Werke GmbH & Co. KG. Polymer bound manganese compounds in cleaning compositions
WO2006132050A1 (ja) 2005-06-07 2006-12-14 Matsushita Electric Industrial Co., Ltd. 酸化亜鉛－タンパク質複合体の製造方法
US20100021391A1 (en) * 2006-07-14 2010-01-28 Montana State University Novel nanoparticles for biofilm targeting
JP4149504B2 (ja) * 2006-12-07 2008-09-10 松下電器産業株式会社 フェリチンを基板上に二次元配列させる方法
JP4149503B2 (ja) * 2006-12-07 2008-09-10 松下電器産業株式会社 フェリチンを基板上に二次元配列させる方法
JP5325427B2 (ja) * 2008-02-20 2013-10-23 株式会社Ｉｈｉ 磁性を有する薬剤
DE102008023228A1 (de) 2008-05-08 2009-11-19 Technische Universität Dresden Nanopartikel zur selektiven Gewebetherapie, Verfahren zu deren Herstellung und deren Verwendung in der Gewebetherapie
JP2011025116A (ja) * 2009-07-22 2011-02-10 Okayama Univ 金属類回収装置
JP5624735B2 (ja) * 2009-07-22 2014-11-12 国立大学法人岡山大学 フィルター
JP5598823B2 (ja) * 2009-08-03 2014-10-01 独立行政法人物質・材料研究機構 有機高分子分離方法
WO2012012786A2 (en) * 2010-07-22 2012-01-26 Brigham Young University Process, composition and method for anion deposition into ferritin for therapeutic and other use
WO2013052167A2 (en) 2011-06-02 2013-04-11 The Regents Of The University Of California Membrane encapsulated nanoparticles and method of use
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
CN106163504B (zh) 2014-03-20 2021-02-09 加利福尼亚大学董事会 水凝胶毒素-吸收或结合纳米颗粒
WO2015187502A1 (en) 2014-06-02 2015-12-10 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
WO2016109306A1 (en) 2015-01-02 2016-07-07 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion
KR101523924B1 (ko) * 2015-02-13 2015-06-01 한국지질자원연구원 철단백질을 이용한 수용성 금속 나노입자의 합성 장치 및 이를 이용해 제조된 수용성 금속 나노입자
CN107530285B (zh) 2015-04-29 2021-07-27 加利福尼亚大学董事会 使用纳米粒子解毒
KR102225790B1 (ko) * 2016-07-08 2021-03-11 나가세 상교오 가부시키가이샤 금속 내포 바구니형 단백질의 제조 방법
JP7312429B2 (ja) * 2019-05-23 2023-07-21 国立大学法人 奈良先端科学技術大学院大学 ゲル組成物及びゲル乾燥物
EP3976636B1 (en) * 2019-05-28 2025-05-21 PreviPharma Consulting GmbH Method for preparing iron-depleted ferritin and use thereof
JP7754614B2 (ja) * 2019-09-03 2025-10-15 株式会社 東北テクノアーチ フェリチン用リンス液

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
DE2656317C2 (de) * 1976-12-11 1986-06-19 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verfahren zur Herstellung einer Suspension von beladenen Erythrocyten
SE443282B (sv) * 1981-06-25 1986-02-24 Alfa Laval Ab Fettprodukt som er bredbar vid kylskapstemperatur samt forfarande for framstellning derav
JPS61174103A (ja) * 1985-01-23 1986-08-05 Shokubai Kasei Kogyo Kk 金属酸化物からなる多孔質真球状微粒子粉末の製造法
DE3688768T2 (de) * 1985-03-05 1993-11-11 Idemitsu Kosan Co Verfahren zur Herstellung von sehr feinen kugelförmigen Metalloxydteilchen.
US4778671A (en) * 1986-07-14 1988-10-18 Corning Glass Works Preparation of unagglomerated metal oxide particles with uniform particle size
US5141634A (en) * 1988-02-03 1992-08-25 Regents Of The University Of Minnesota High stability porous zirconium oxide spherules
US5108597A (en) * 1990-03-22 1992-04-28 Regents Of The University Of Minnesota Carbon-clad zirconium oxide particles
US5173454A (en) * 1992-01-09 1992-12-22 Corning Incorporated Nanocrystalline materials

Also Published As

Publication number Publication date
EP0487615B1 (en) 1994-01-05
CA2064069A1 (en) 1991-02-19
KR920703473A (ko) 1992-12-18
EP0487615A1 (en) 1992-06-03
DE69005827T2 (de) 1994-07-28
AU641936B2 (en) 1993-10-07
JPH04507255A (ja) 1992-12-17
DE69005827D1 (de) 1994-02-17
WO1991002704A1 (en) 1991-03-07
US5358722A (en) 1994-10-25
ATE99656T1 (de) 1994-01-15
KR950002917B1 (ko) 1995-03-28
US5304382A (en) 1994-04-19
AU6296790A (en) 1991-04-03
DK0487615T3 (da) 1994-03-14

Similar Documents

Publication Publication Date Title
ES2062551T3 (es) Analogos de ferritina.
AR246985A1 (es) Un procedimiento para preparar dextrosa de alta pureza.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
AU1506088A (en) Alkylated polyalkylenepolyamines, substituted oxo-piperazinyl-triazines and uv light stabilized compositions
DE3168681D1 (en) D-homo steroids, their utilization and preparation and pharmaceutical compositions containing them
CA950143A (en) Flame resistant composition of abs, polyarylene polysulfone and brome-aryl compound
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IL67849A0 (en) Panthanol derivatives,their manufacture and pharmaceutical compositions containing them
GB1363404A (en) Epoxides
AU474102B2 (en) Process for the production of alkylated n, n'- diphenyloxamides
ES2032100T3 (es) Procedimiento para la preparacion de alcanodioles.
ES2002019A6 (es) Procedimiento de preparacion de un nuevo derivado del tiocromano
NO156418C (no) FremgangsmŸte for fremstillng av antimikrobielt og antitumorantibiotikum m 9026 og dets rene individuelle faktorer 1, 2 og 3.
AU1595583A (en) Cathode of gp viii plus oxide of ge, ga, ta or w
USD173014S (en) Base for table lamps
Adderley et al. Work song
SE7910157L (sv) Substituerade 2-fenylaminoimidazolin-(2)-er med speciella teraputiska egenskaper, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem
ES444600A1 (es) Un procedimiento de obtencion de los 3-azadiespirodecanos.
JPS51150890A (en) Fluorescent lamp
IT8200204V0 (it) Lettera illustrata senza busta
CA883444A (en) Alloy for hollow cathode lamp
CA856223A (en) Separation of formaldehyde from hydrogen peroxide
CA851180A (en) 4'-HYDROXY (OR ACYLOXY)-(STEROID-2,5'-M-DIOXAN)-3-ONE, SPIRO(STEROID-2,3'(2'.alpha.)-PYRAZOLIN)-3-ONE, INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
AU453524B2 (en) 2, 2-diaryl-4(4'aryl-4'-hydroxy piperidino) butyramides

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 487615

Country of ref document: ES